500 related articles for article (PubMed ID: 9454887)
41. p53 alteration and human papilloma virus infection in paranasal sinus cancer.
Caruana SM; Zwiebel N; Cocker R; McCormick SA; Eberle RC; Lazarus P
Cancer; 1997 Apr; 79(7):1320-8. PubMed ID: 9083153
[TBL] [Abstract][Full Text] [Related]
42. Squamous cell carcinoma of the endometrium with human papillomavirus type 31 and without tumor suppressor gene p53 mutation.
Kataoka A; Nishida T; Sugiyama T; Hori K; Honda S; Yakushiji M
Gynecol Oncol; 1997 Apr; 65(1):180-4. PubMed ID: 9103411
[TBL] [Abstract][Full Text] [Related]
43. Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma.
Portugal LG; Goldenberg JD; Wenig BL; Ferrer KT; Nodzenski E; Sabnani JB; Javier C; Weichselbaum RR; Vokes EE
Arch Otolaryngol Head Neck Surg; 1997 Nov; 123(11):1230-4. PubMed ID: 9366703
[TBL] [Abstract][Full Text] [Related]
44. Detection of human papillomavirus DNA and p53 gene mutations in esophageal cancer samples and adjacent normal mucosa.
Astori G; Merluzzi S; Arzese A; Brosolo P; de Pretis G; Maieron R; Pipan C; Botta GA
Digestion; 2001; 64(1):9-14. PubMed ID: 11549832
[TBL] [Abstract][Full Text] [Related]
45. Association of human papillomavirus type 11 DNA with squamous cell carcinoma of the tongue.
Fife KH; Fan L; Fritsch MH; Bryan J; Brown DR
Arch Otolaryngol Head Neck Surg; 1996 Dec; 122(12):1404-8. PubMed ID: 8956761
[TBL] [Abstract][Full Text] [Related]
46. Mutated and wild-type p53 expression and HPV integration in proliferative verrucous leukoplakia and oral squamous cell carcinoma.
Gopalakrishnan R; Weghorst CM; Lehman TA; Calvert RJ; Bijur G; Sabourin CL; Mallery SR; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Apr; 83(4):471-7. PubMed ID: 9127380
[TBL] [Abstract][Full Text] [Related]
47. Presence of human papillomavirus sequences in tumour-derived human oral keratinocytes expressing mutant p53.
Yeudall WA; Paterson IC; Patel V; Prime SS
Eur J Cancer B Oral Oncol; 1995 Mar; 31B(2):136-43. PubMed ID: 7633286
[TBL] [Abstract][Full Text] [Related]
48. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis.
van Duin M; Snijders PJ; Vossen MT; Klaassen E; Voorhorst F; Verheijen RH; Helmerhorst TJ; Meijer CJ; Walboomers JM
J Gen Virol; 2000 Feb; 81(Pt 2):317-25. PubMed ID: 10644829
[TBL] [Abstract][Full Text] [Related]
49. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas.
van Houten VM; Snijders PJ; van den Brekel MW; Kummer JA; Meijer CJ; van Leeuwen B; Denkers F; Smeele LE; Snow GB; Brakenhoff RH
Int J Cancer; 2001 Jul; 93(2):232-5. PubMed ID: 11410871
[TBL] [Abstract][Full Text] [Related]
50. Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines.
Min BM; Baek JH; Shin KH; Gujuluva CN; Cherrick HM; Park NH
Eur J Cancer B Oral Oncol; 1994 Sep; 30B(5):338-45. PubMed ID: 7703804
[TBL] [Abstract][Full Text] [Related]
51. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53.
Rady PL; Schnadig VJ; Weiss RL; Hughes TK; Tyring SK
Laryngoscope; 1998 May; 108(5):735-40. PubMed ID: 9591556
[TBL] [Abstract][Full Text] [Related]
52. Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters.
Brady CS; Duggan-Keen MF; Davidson JA; Varley JM; Stern PL
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3233-3240. PubMed ID: 10567656
[TBL] [Abstract][Full Text] [Related]
53. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
[TBL] [Abstract][Full Text] [Related]
54. Human papillomavirus type 38 infection in oral squamous cell carcinomas.
Kojima A; Maeda H; Sugita Y; Tanaka S; Kameyama Y
Oral Oncol; 2002 Sep; 38(6):591-6. PubMed ID: 12167437
[TBL] [Abstract][Full Text] [Related]
55. Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma.
Jung AC; Briolat J; Millon R; de Reyniès A; Rickman D; Thomas E; Abecassis J; Clavel C; Wasylyk B
Int J Cancer; 2010 Apr; 126(8):1882-1894. PubMed ID: 19795456
[TBL] [Abstract][Full Text] [Related]
56. [p53 alterations and HPV status in oral squamous cell carcinomas].
Barten M; Ostwald C; Müller P; Löning T; Milde-Langosch K; Wukasch Y
Verh Dtsch Ges Pathol; 1994; 78():255-9. PubMed ID: 7533995
[TBL] [Abstract][Full Text] [Related]
57. Detection of human papillomavirus in squamous cell carcinomas of the lung by polymerase chain reaction.
Bohlmeyer T; Le TN; Shroyer AL; Markham N; Shroyer KR
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):265-9. PubMed ID: 9476914
[TBL] [Abstract][Full Text] [Related]
58. Detection of the human papillomavirus and analysis of the TP53 polymorphism of exon 4 at codon 72 in penile squamous cell carcinomas.
Humbey O; Cairey-Remonnay S; Guérrini JS; Algros MP; Mougin C; Bittard H; Aubin F
Eur J Cancer; 2003 Mar; 39(5):684-90. PubMed ID: 12628849
[TBL] [Abstract][Full Text] [Related]
59. A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas.
Koyamatsu Y; Yokoyama M; Nakao Y; Fukuda K; Saito T; Matsukuma K; Iwasaka T
Gynecol Oncol; 2003 Sep; 90(3):547-51. PubMed ID: 13678722
[TBL] [Abstract][Full Text] [Related]
60. Quantitative polymerase chain reaction-based detection of HPV 16 E6 and E7 DNA in oral squamous cell carcinoma.
Thammaiah S; Venkobarao MC; Sathyavanthan H; Mirnalini AS
J Oral Pathol Med; 2018 Oct; 47(9):873-879. PubMed ID: 30059164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
